Axelopran

DB12013

small molecule investigational

Deskripsi

Axelopran has been used in trials studying the treatment of OIC and Opioid-induced Constipation.

Struktur Molekul 2D

Berat 457.615
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

54 Data
Methylnaltrexone Axelopran may increase the opioid antagonism activities of Methylnaltrexone.
Naloxegol Axelopran may increase the opioid antagonism activities of Naloxegol.
Tramadol The therapeutic efficacy of Tramadol can be decreased when used in combination with Axelopran.
Morphine The therapeutic efficacy of Morphine can be decreased when used in combination with Axelopran.
Codeine The therapeutic efficacy of Codeine can be decreased when used in combination with Axelopran.
Hydromorphone The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Axelopran.
Methadone The therapeutic efficacy of Methadone can be decreased when used in combination with Axelopran.
Meperidine The therapeutic efficacy of Meperidine can be decreased when used in combination with Axelopran.
Oxycodone The therapeutic efficacy of Oxycodone can be decreased when used in combination with Axelopran.
Butorphanol The therapeutic efficacy of Butorphanol can be decreased when used in combination with Axelopran.
Dextropropoxyphene The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Axelopran.
Pentazocine The therapeutic efficacy of Pentazocine can be decreased when used in combination with Axelopran.
Naltrexone The therapeutic efficacy of Naltrexone can be decreased when used in combination with Axelopran.
Sufentanil The therapeutic efficacy of Sufentanil can be decreased when used in combination with Axelopran.
Alfentanil The therapeutic efficacy of Alfentanil can be decreased when used in combination with Axelopran.
Fentanyl The therapeutic efficacy of Fentanyl can be decreased when used in combination with Axelopran.
Nalbuphine The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Axelopran.
Levorphanol The therapeutic efficacy of Levorphanol can be decreased when used in combination with Axelopran.
Remifentanil The therapeutic efficacy of Remifentanil can be decreased when used in combination with Axelopran.
Buprenorphine The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Axelopran.
Hydrocodone The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Axelopran.
Diphenoxylate The therapeutic efficacy of Diphenoxylate can be decreased when used in combination with Axelopran.
Oxymorphone The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Axelopran.
Dezocine The therapeutic efficacy of Dezocine can be decreased when used in combination with Axelopran.
Levacetylmethadol The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Axelopran.
Methadyl acetate The therapeutic efficacy of Methadyl acetate can be decreased when used in combination with Axelopran.
Dihydroetorphine The therapeutic efficacy of Dihydroetorphine can be decreased when used in combination with Axelopran.
Diamorphine The therapeutic efficacy of Diamorphine can be decreased when used in combination with Axelopran.
Bezitramide The therapeutic efficacy of Bezitramide can be decreased when used in combination with Axelopran.
Ethylmorphine The therapeutic efficacy of Ethylmorphine can be decreased when used in combination with Axelopran.
Etorphine The therapeutic efficacy of Etorphine can be decreased when used in combination with Axelopran.
Dextromoramide The therapeutic efficacy of Dextromoramide can be decreased when used in combination with Axelopran.
Desomorphine The therapeutic efficacy of Desomorphine can be decreased when used in combination with Axelopran.
Carfentanil The therapeutic efficacy of Carfentanil can be decreased when used in combination with Axelopran.
Dihydrocodeine The therapeutic efficacy of Dihydrocodeine can be decreased when used in combination with Axelopran.
Alphacetylmethadol The therapeutic efficacy of Alphacetylmethadol can be decreased when used in combination with Axelopran.
Dihydromorphine The therapeutic efficacy of Dihydromorphine can be decreased when used in combination with Axelopran.
Tapentadol The therapeutic efficacy of Tapentadol can be decreased when used in combination with Axelopran.
Ketobemidone The therapeutic efficacy of Ketobemidone can be decreased when used in combination with Axelopran.
DPDPE The therapeutic efficacy of DPDPE can be decreased when used in combination with Axelopran.
Lofentanil The therapeutic efficacy of Lofentanil can be decreased when used in combination with Axelopran.
Eluxadoline The therapeutic efficacy of Eluxadoline can be decreased when used in combination with Axelopran.
Opium The therapeutic efficacy of Opium can be decreased when used in combination with Axelopran.
Normethadone The therapeutic efficacy of Normethadone can be decreased when used in combination with Axelopran.
Piritramide The therapeutic efficacy of Piritramide can be decreased when used in combination with Axelopran.
Alphaprodine The therapeutic efficacy of Alphaprodine can be decreased when used in combination with Axelopran.
Nicomorphine The therapeutic efficacy of Nicomorphine can be decreased when used in combination with Axelopran.
Meptazinol The therapeutic efficacy of Meptazinol can be decreased when used in combination with Axelopran.
Phenoperidine The therapeutic efficacy of Phenoperidine can be decreased when used in combination with Axelopran.
Phenazocine The therapeutic efficacy of Phenazocine can be decreased when used in combination with Axelopran.
Tilidine The therapeutic efficacy of Tilidine can be decreased when used in combination with Axelopran.
Carfentanil, C-11 The therapeutic efficacy of Carfentanil, C-11 can be decreased when used in combination with Axelopran.
Benzhydrocodone The therapeutic efficacy of Benzhydrocodone can be decreased when used in combination with Axelopran.
Oliceridine The therapeutic efficacy of Oliceridine can be decreased when used in combination with Axelopran.

Target Protein

Mu-type opioid receptor OPRM1

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul